Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501338 · ClinicalTrials.gov registry record · NA
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT07501338: Clinical Trial NA study, sponsored by Stanford University.
NCT07501338 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07501338, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.
Primary Outcome
Timing of AID initiation will be measured by the number of participants initiating AID system within 2 weeks of diabetes diagnosis
Interventions
- DEVICE Tandem Automated Insulin Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-03 |
| Phase | NA |
What is known before NCT07501338 opens enrollment
NCT07501338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Tandem Automated Insulin Delivery System is the first listed.
NCT07501338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07501338 about?
NCT07501338 is a clinical study titled "Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D". Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools f...
What is the current status of trial NCT07501338?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-03. Estimated completion is 2031-03.
What interventions are being tested in trial NCT07501338?
The interventions under investigation include: Tandem Automated Insulin Delivery System (DEVICE).
Who is sponsoring clinical trial NCT07501338?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07501338's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia